Understanding multiple myeloma: Challenges and solutions

Dr Flordeluna Z. Mesina, University of Santo Tomas Hospital - PCHTM, Manila, Philippines
Understanding multiple myeloma: Challenges and solutions ( Dr Flordeluna Z. Mesina, University of Santo Tomas Hospital - PCHTM, Manila, Philippines )
22 Apr 2025

Improving cancer care access in the Philippines

Dr Jasmin R. Igama, Philippine Society of Medical Oncology, Manila, Philippines
Improving cancer care access in the Philippines ( Dr Jasmin R. Igama, Philippine Society of Medical Oncology, Manila, Philippines )
22 Apr 2025

Understanding smouldering multiple myeloma: Diagnosis and challenges

Dr Maria Clariza M. Santos, Philippine General Hospital, Manila, Philippines
Understanding smouldering multiple myeloma: Diagnosis and challenges ( Dr Maria Clariza M. Santos, Philippine General Hospital, Manila, Philippines )
22 Apr 2025

I can’t wait forever: Treatment of smouldering multiple myeloma (SMM)

Dr Maria Clariza M. Santos - Philippine General Hospital, Manila , Filipinas
I can’t wait forever: Treatment of smouldering multiple myeloma (SMM) ( Dr Maria Clariza M. Santos - Philippine General Hospital, Manila , Filipinas )
22 Apr 2025

From diagnosis to dignity: Palliative care in multiple myeloma

Dr Noel P. Pingoy - General Santos Doctors Hospital, General Santos City, Filipinas
From diagnosis to dignity: Palliative care in multiple myeloma ( Dr Noel P. Pingoy - General Santos Doctors Hospital, General Santos City, Filipinas )
22 Apr 2025

Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients

Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston, USA
Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients ( Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston, USA )
11 Mar 2025

Prophylactic tocilizumab prior to infusion of anti-CD19 CAR-T ce may reduce toxicity in older lymphoma patients

Dr Wiebke Rösler - University Hospital Zurich, Zurich, Switzerland
Prophylactic tocilizumab prior to infusion of anti-CD19 CAR-T ce may reduce toxicity in older lymphoma patients ( Dr Wiebke Rösler - University Hospital Zurich, Zurich, Switzerland )
13 Feb 2025

Advancements in pharmacovigilance in East Africa

Felix Mochache - Novartis, Nairobi, Kenya
Advancements in pharmacovigilance in East Africa ( Felix Mochache - Novartis, Nairobi, Kenya )
6 Feb 2025

Understanding pharmacovigilance in Namibia

Chelsea Moller - Namibia Medicines Regulatory Council (NMRC), Windhoek, Namibia
Understanding pharmacovigilance in Namibia ( Chelsea Moller - Namibia Medicines Regulatory Council (NMRC), Windhoek, Namibia )
6 Feb 2025

Advances in pharmacovigilance in Nigeria

Dr Elemuwa Uchenna G - Pharmacovigilance National Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria
Advances in pharmacovigilance in Nigeria ( Dr Elemuwa Uchenna G - Pharmacovigilance National Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria )
6 Feb 2025

Enhancing multiple myeloma care in western Kenya

Ms Mercy Oduor - AMPATH Kenya, Eldoret, Kenya
Enhancing multiple myeloma care in western Kenya ( Ms Mercy Oduor - AMPATH Kenya, Eldoret, Kenya )
20 Jan 2025

The AMPATH multiple myeloma programme model

Ms Mercy Oduor - AMPATH Kenya, Eldoret, Kenya
The AMPATH multiple myeloma programme model ( Ms Mercy Oduor - AMPATH Kenya, Eldoret, Kenya )
20 Jan 2025